Home
Resources
Follow portfolio news
...

BluWave names Cressey & Company in the top 2% of most innovative private equity managers in the U.S.

Published on
20/5/2025
Amended on
15/4/2026
0
minute(s)
Odyssey 2022
Cressey
Cressey & Company, Fund manager in the Vintage FPCI Altaroc Odyssey , has been named a recipient of the “Top Private Equity Innovator Award 2025,” organized by the expert platform BluWave. This distinction ranks the Chicago-based firm among the top 2% of the most innovative private equity firms in the most dynamic and competitive market: North America.
By
Antoine Orsoni
Antoine Orsoni
BluWave names Cressey & Company in the top 2% of most innovative private equity managers in the U.S.
This article has been automatically translated. Please excuse any inaccuracies or translation errors.
Dieser Artikel wurde automatisch übersetzt. Bitte entschuldigen Sie etwaige Ungenauigkeiten oder Übersetzungsfehler.
This article has been automatically translated. We apologize per inaccuracies or translation errors.

This recognition highlights the excellence of Cressey & Company in implementing distinctive practices in due diligence , value creation, modern internal operations, and family business culture. The rigorous and independent selection process evaluated more than 6,000 firms based on 75 criteria and over 400,000 data points, in consultation with institutional investors, investment bankers, and industry experts. This list of criteria aligns well with BluWave’s DNA, an expert platform that connects private equity firms with specialized service providers to accelerate value creation, optimize due diligence, and professionalize operations.

Founded over 40 years ago, the Fund manager one of the first of its kind in the United States. It specializes in investments targeting the healthcare and information technology sectors. With $3.7 billion in assets under management, the firm has established partnerships with more than 35 companies, focusing on proven business models and significant growth prospects. Cressey & Company approach, summarized by the principles “Target, Partner, Build,” consists of identifying high-potential segments, collaborating closely with experienced management teams, and building innovative and sustainable companies in the healthcare sector.

Other episodes on this topic

Explore our content collections, which bring together different formats around a single subject/issue/theme.
No articles in this category yet.
No items found.
North America
Healthcare
Welcome to Altaroc
To provide you with a tailored experience, please complete your profile.
Your profile
country of tax residence
Select
choosenCountry
Preferred language
Select
choosenLang
YOUR INVESTOR PROFILE
Financial intermediary or professional investor
Financial advisors, wealth managers, private bankers, or any other investment service providers.
Qualified Investor or Altaroc Investor
Experienced investor or Altaroc investor
Private investors who have already invested with Altaroc or who have a minimum investment capacity of €100,000.
Private investors who have previously invested in Altaroc who have a minimum investment capacity of 200,000 euros.
Non-professional (retail) investor
Individual investors with an investment capacity below €100,000.
Retail investors with an investment capacity of less than 200,000 euros.
Institutional investor
Pension funds, retirement schemes, asset management companies, and single-family offices.
Scroll down to accept General Terms and Conditions
The webpage you are trying to access is not available in your country.